60 filings
Page 3 of 3
8-K
7azuw9k4
11 Feb 22
Developing innovative therapeutics and diagnostics to address unmet needs Corporate Presentation / February 2022 www.revbiosciences.com
12:00am
8-K
h2l6qqpv4l03 da3
27 Jan 22
Entry into a Material Definitive Agreement
4:05pm
8-K
h14b1
14 Jan 22
Completion of Acquisition or Disposition of Assets
4:28pm
8-K
ak1g4c6l1tx3x tj2
13 Jan 22
Developing innovative therapeutics and diagnostics to address unmet needs Corporate Presentation / January 2022
3:53pm
8-K
jyxgqymb3su
12 Jan 22
Amendments to Articles of Incorporation or Bylaws
4:49pm
8-K
u1ame
23 Dec 21
Petra Acquisition, Inc. Announces Share Redemption Backstop and Forward Purchase Agreements in Revelation Biosciences, Inc. Business Combination
5:27pm
8-K
x4cujq3 zu92mwfgro
17 Dec 21
Other Events
3:31pm
8-K
sb8are8vgsiwmyg8nw0u
24 Nov 21
Other Events
5:17pm
8-K
f75wzv8nejwvilfejt3n
19 Oct 21
Entry into a Material Definitive Agreement
5:23pm
8-K
nzz1mqw gdlc
13 Oct 21
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
yh8wkax6
23 Sep 21
Entry into a Material Definitive Agreement
5:22pm
8-K
r9x1k3 tlkex1w930c
2 Sep 21
Entry into a Material Definitive Agreement
5:11pm
8-K
g3hnfd98a7vz9x
31 Aug 21
Regulation FD Disclosure
6:06am
8-K
mbuo5a43x7 ii14
16 Jun 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:43pm
8-K
w8x8fhfzodjsidcbsw
1 Jun 21
Petra Acquisition, Inc. Receives Expected Nasdaq Notification Regarding Delayed Form 10-Q
4:31pm
8-K/A
o67wi2
5 Mar 21
Departure of Directors or Certain Officers
4:54pm
8-K
zvlik6 kbh
23 Feb 21
Departure of Directors or Certain Officers
4:00pm
8-K
m5vyvsk2d f80i
10 Nov 20
Petra Acquisition, Inc. Announces Securities to Commence Separate Trading
4:05pm
8-K
10f589p
19 Oct 20
Index to Financial Statement
5:30pm
8-K
j9cnw5ko2u
13 Oct 20
Petra Acquisition Inc. Announces Pricing of $70 Million Initial Public Offering
5:20pm